Author

M. Toguchi

Observed names: M. S. Toguchi, Marcia S. TOGUCHI, Marcia Toguchi

Observed institutions: Karolinska Institutet, Astex Pharmaceuticals, The University of Osaka

OpenAlex ID: A5111618486

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group

2016 · Matthew D. Seftel, John Kuruvilla, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 50

Members of the CIP4 family of proteins participate in the regulation of platelet‐derived growth factor receptor‐β‐dependent actin reorganization and migration

2009 · Marcia Toguchi, Ninna Richnau, et al. · Biology of the Cell · 34

Neurotrophic effect of Semaphorin 4D in PC12 cells

2003 · Shiho Fujioka, Kenta Masuda, et al. · Biochemical and Biophysical Research Communications · 34

Involvement of Sema4D in the control of microglia activation

2009 · Marcia Toguchi, Daniel Gonzalez, et al. · Neurochemistry International · 32

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia

2016 · B. Vormoor, G. J. Veal, et al. · Pediatric Blood & Cancer · 31

Studies on cytotoxic effect of nickel ions on three cultured fibroblasts

2001 · M. Taira, M. S. Toguchi, et al. · Journal of Materials Science Materials in Medicine · 30

Improvement of Bond Strength in Metal-Ceramic Systems Using a Gold Intermediate Layer.

1998 · Masayuki OKAZAKI, Xue WANG, et al. · Dental Materials Journal · 17

Studies on cytotoxicity of nickel ions using C3H10T1/2 fibroblast cells

2000 · M. Taira, M. S. Toguchi, et al. · Journal of Oral Rehabilitation · 12

Cytotoxicity of three di-functional monomers used in dental composite resins

2000 · M. Taira, M. S. Toguchi, et al. · Journal of Materials Science Letters · 9

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients with Chronic Lymphocytic Leukemia: NCIC CTG Trial IND.193

2014 · Matthew D. Seftel, John Kuruvilla, et al. · Blood · 4

Abstract CT108: A first-in-human, Phase 1 study of ASTX029, a dual-mechanism inhibitor of ERK1/2, in relapsed/refractory solid tumors

2021 · Patricia LoRusso, Drew Rasco, et al. · Cancer Research

Involvement of Sema4D in the migration and morphology of murine microglia

2005 · M. Toguchi · OUKA (Osaka University Knowledge Archive) (Osaka University)

Works count: 12

Citation count: 253

H-index: 9

I10-index: 8